Slingshot members are tracking this event:

New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 28, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Zavicefta, Bacterial Infections, Gram-negative Bacterial Infections, P. Aeruginosa, Arbapenem-resistant Gram-negative Pathogens, Enterobacteriaceae